Barclays PLC Singular Genomics Systems, Inc. Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$0.78 - $1.28 $22,460 - $36,857	-28,795 Reduced 70.1%	12,284 $10,000
Q1 2023 May 04, 2023	BUY	$1.1 - $2.95 $15,001 - $40,232	13,638 Added 49.7%	41,079 $50,000
Q4 2022 Feb 13, 2023	BUY	$1.82 - $2.71 $23,283 - $34,669	12,793 Added 87.34%	27,441 $56,000
Q3 2022 Nov 03, 2022	SELL	$2.5 - $4.73 $1,082 - $2,048	-433 Reduced 2.87%	14,648 $37,000
Q2 2022 Aug 12, 2022	SELL	$2.86 - $6.44 $2,156 - $4,855	-754 Reduced 4.76%	15,081 $58,000
Q1 2022 May 16, 2022	BUY	$5.94 - $12.09 $94,059 - $191,445	15,835 New	15,835 $100,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.41B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.